Twist Bioscience Corporation
TWST
$47.66
-$1.98-3.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.89% | 16.88% | 17.91% | 23.23% | 24.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.89% | 16.88% | 17.91% | 23.23% | 24.08% |
| Cost of Revenue | 8.40% | 3.65% | -3.10% | 5.28% | 7.85% |
| Gross Profit | 25.99% | 32.97% | 45.44% | 49.04% | 47.92% |
| SG&A Expenses | 24.15% | 19.97% | 11.58% | 14.47% | 6.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.73% | 6.78% | 0.57% | 8.18% | 4.12% |
| Operating Income | 5.03% | 16.95% | 31.53% | 14.99% | 26.25% |
| Income Before Tax | 3.95% | 22.65% | 124.11% | 13.28% | 26.56% |
| Income Tax Expenses | 160.82% | 367.71% | 0.00% | -49.28% | -19.17% |
| Earnings from Continuing Operations | 3.44% | 21.69% | 123.83% | 13.55% | 26.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.44% | 21.69% | 123.83% | 13.55% | 26.54% |
| EBIT | 5.03% | 16.95% | 31.53% | 14.99% | 26.25% |
| EBITDA | 5.45% | 16.12% | 32.60% | 13.38% | 26.39% |
| EPS Basic | 6.46% | 24.11% | 123.10% | 16.26% | 28.61% |
| Normalized Basic EPS | 6.94% | 25.05% | 32.27% | 16.01% | 28.64% |
| EPS Diluted | 6.46% | 24.28% | 122.42% | 16.26% | 28.61% |
| Normalized Diluted EPS | 6.94% | 25.05% | 33.58% | 16.01% | 28.64% |
| Average Basic Shares Outstanding | 3.24% | 3.19% | 3.18% | 3.24% | 2.90% |
| Average Diluted Shares Outstanding | 3.24% | 3.19% | 5.19% | 3.24% | 2.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |